A repurposing development team is a group of experts from various disciplines, including scientists, clinicians, patient representatives, regulatory professionals, intellectual property lawyers, and commercialization specialists, who work together to evaluate an existing drug’s potential for use in a new therapeutic indication. The team typically develops and executes a repurposing development plan, which includes preclinical and clinical studies to assess the drug’s safety and efficacy in the new indication, as well as regulatory, intellectual property, market entry route, pricing and reimbursement considerations. The team works collaboratively to ensure that the repurposing effort is scientifically sound, financially viable, and meets regulatory requirements, with the goal of bringing the repurposed drug to market as quickly and efficiently as possible.
